http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20100088144-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28e3113097dd6d28720572e47f2f2407 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4188 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4188 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2008-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_814e74c18ecff4448d7e3b53bdd47e63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d76a61d1bb9bedbc748b533846c84b53 |
publicationDate | 2010-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20100088144-A |
titleOfInvention | Pyrrolo [1,2-C] imidazole derivatives for use in the prevention or treatment of cancers refractory to known cancer therapies |
abstract | The present invention mainly aims to provide a prophylactic or therapeutic drug for androgen-independent prostate cancer, which is very useful as a medicament. The present invention provides a steroid C? 17,20 # 191 lyase inhibitor, in particular a drug for the prevention or treatment of androgen-independent prostate cancer containing a compound represented by the following formula (I) or a salt thereof or a prodrug thereof: (Wherein n is an integer of 1 to 3 and Ar is an aromatic ring optionally having substituent (s)). |
priorityDate | 2007-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 648.